Paolo Martelletti

Paolo Martelletti

Sapienza Università di Roma

H-index: 60

Europe-Italy

About Paolo Martelletti

Paolo Martelletti, With an exceptional h-index of 60 and a recent h-index of 47 (since 2020), a distinguished researcher at Sapienza Università di Roma, specializes in the field of Medicina Interna, Cefalee, Dolore.

His recent articles reflect a diverse array of research interests and contributions to the field:

Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway

Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention

Unmet needs in the acute treatment of migraine

Potential benefits and possible risks of multitherapy CGRP-targeted in migraine

The Preoperative Assessment of Frailty in the Setting of Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review

Mechanosensitive receptors in migraine: a systematic review

A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health?

The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action …

Paolo Martelletti Information

University

Position

Professore Associato di Medicina Interna

Citations(all)

13597

Citations(since 2020)

8530

Cited By

8070

hIndex(all)

60

hIndex(since 2020)

47

i10Index(all)

244

i10Index(since 2020)

163

Email

University Profile Page

Sapienza Università di Roma

Google Scholar

View Google Scholar Profile

Paolo Martelletti Skills & Research Interests

Medicina Interna

Cefalee

Dolore

Top articles of Paolo Martelletti

Title

Journal

Author(s)

Publication Date

Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway

Dental and Medical Problems

Marta Waliszewska-Prosół

Paolo Martelletti

2024

Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention

Lanfranco Pellesi

Messoud Ashina

Paolo Martelletti

2024/2/12

Unmet needs in the acute treatment of migraine

Advances in Therapy

Enrico Bentivegna

Silvia Galastri

Dilara Onan

Paolo Martelletti

2024/1

Potential benefits and possible risks of multitherapy CGRP-targeted in migraine

Keiko Ihara

Tsubasa Takizawa

Narumi Watanabe

Jin Nakahara

Paolo Martelletti

2024/2/8

The Preoperative Assessment of Frailty in the Setting of Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review

Antonio Martocchia

Laura Vero

Denise Pezzella

Silvia Sciaulino

Lorenzo Caracciolo

...

2024/12

Mechanosensitive receptors in migraine: a systematic review

Adriana Della Pietra

Laura Gómez Dabó

Petr Mikulenka

Christian Espinoza-Vinces

Doga Vuralli

...

2024/1/15

A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health?

Alberto Raggi

Matilde Leonardi

Paolo Martelletti

2024/4/20

The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action …

Matilde Leonardi

Paolo Martelletti

Rami Burstein

Arianna Fornari

Licia Grazzi

...

2024/1/4

Placebo responses vary by route of administration in migraine prevention trials. What does this mean?

Christina I Deligianni

Paolo Martelletti

Dimos D Mitsikostas

2024/2/26

Potential benefits and possible risks of CGRP-targeted multitherapy in migraine

Keiko Ihara

Tsubasa Takizawa

Narumi Watanabe

Jin Nakahara

Paolo Martelletti

2024

Patient Sex in Prescribing CGRP Receptor Antagonists for Migraine

JAMA neurology

Michel Lanteri-Minet

Shuu-Jiun Wang

Paolo Martelletti

2024/2/26

Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal

William Wells-Gatnik

Paolo Martelletti

2023/9/2

Gepants in the acute management of migraine

William David Wells-Gatnik

Paolo Martelletti

2023/11

Long-term course of COVID-19 vaccination-related headache: A prospective multicenter follow-up study

International Headache Congress (IHC)

Arife Cimen Atalar

Ayşe Nur Özdağ Acarlı

Betül Baykan

Hayrunnisa Bolay

Mustafa Ertaş

...

2023

COVID-19 and SARS-CoV-2 vaccines: a cameo role for headache

International Journal of Environmental Research and Public Health

Paolo Martelletti

2023/2/22

What Is the Best Methodology for Headache or Migraine Research?

Cristina Gaglianone

Enrico Bentivegna

Paolo Martelletti

2023/3/31

The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization

Pınar Yalinay Dikmen

Aynur Ozge

Paolo Martelletti

2023/5/13

Emerging experimental drugs in clinical trials for migraine: observations and key talking points

William David Wells-Gatnik

Tiffany Yazmin Wences Chirino

Fatma Nur Onan

Dilara Onan

Paolo Martelletti

2023/8/3

The measurement of the left ventricle ejection fraction by a bedside FoCUS examination

Internal and Emergency Medicine

Antonio Martocchia

Cinzia Piccoli

Michele Fortunato Notarangelo

Daniela Sergi

Beata Ostrowska

...

2023/11

The efficacy of physical therapy and rehabilitation approaches in chronic migraine: a systematic review and meta-analysis

Dilara Onan

Esme Ekizoğlu

Halime Arıkan

Bahar Taşdelen

Aynur Özge

...

2023

See List of Professors in Paolo Martelletti University(Sapienza Università di Roma)